agent

(redirected from therapeutic agent)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial.

agent

a person representing a business concern, esp a travelling salesman

Agent

 

in Soviet civil law, a party in a contract of agency. The agent’s duties include the performance of specified legal acts, for example, contracts of sale and management of property, in the name of and on the account of a principal party. The agent may be a legally competent (sui juris) citizen or a legal person (if this is allowed by the latter’s charter or statute). The actions performed by the agent directly generate, change, or extinguish rights and obligations of the principal.

The agent is bound to perform the agency in exact conformity with the principal’s instructions, carry out the agency personally, although in instances provided for by law the responsibilities may be transferred to another person (art. 68 of the RSFSR Civil Code), inform the principal upon demand of progress in performing the agency, submit a report on performance of the agency, and transfer to the principal any property obtained in connection with performance of the agency.

agent

One who is empowered to enter into binding transactions on behalf of another (usually called the principal).

agent

(networking)
In the client-server model, the part of the system that performs information preparation and exchange on behalf of a client or server. Especially in the phrase "intelligent agent" it implies some kind of automatic process which can communicate with other agents to perform some collective task on behalf of one or more humans.

agent

A software routine that waits in the background and performs an action when a specified event occurs. For example, agents could transmit a summary file on the first day of the month or monitor incoming data and alert the user when a certain transaction has arrived. Agents are also called "intelligent agents," "personal agents" and "bots." See mobile agent, bot and workflow.
References in periodicals archive ?
Bcl-2 homology domain-3 (BH3) peptides are potent therapeutic agents that are currently used in cancer treatment.
This new patent is broadly directed to various classes of therapeutic agents with the potential to impact the PI3-kinase pathway including short interfering RNA (siRNA) molecules, antibodies and small molecules, among others.
These statements include, but are not limited to, those relating to the expected filing of an Investigational New Drug application for ALTU-237 in the first half of 2007, plans for initiating a Phase III trial of ALTU-135 in the second quarter of 2007, the Company's encouragement from the pre-clinical results of ALTU-237 and the potential start of its clinical program next year, and the potential for ALTU-237 to be the first effective therapeutic agent specifically designed to reduce oxalate levels, prevent the formation of kidney stones and treat primary hyperoxaluria.
Longer circulation time in plasma delivers more of the therapeutic agent to targeted tumor sites over a longer period of time.
This patent covers methods and compositions for reducing toxicity of a toxic agent in which a polysaccharide, galactomannan, is co-administered with a therapeutic agent in a liquid formulation to a subject to reduce toxicity of the agent for the subject.
M2 EQUITYBITES-November 30, 2015-biOasis wins US patent for delivery of therapeutic agents across the blood-brain barrier using polypeptides from Transcend BBB delivery vector
M2 PHARMA-November 30, 2015-biOasis wins US patent for delivery of therapeutic agents across the blood-brain barrier using polypeptides from Transcend BBB delivery vector
Contract notice: In addition to the delivery of therapeutic agents.